GSK Plc and Flagship Pioneering Inc. entered a partnership to develop as many as 10 new drugs in a deal that could pay more than $7 billion to firms supported by the venture capital biotech ...

GSK plc: Long-Term Cash Cow GSK Breathes New Life Into Asthma Treatment With Depemokimab GSK plc (GSK) Q1 2024 Earnings Call ...

Cows from Texas likely infected healthy cows in Ohio and probably spread the virus to cats, a racoon and wild birds on farms ...

GSK plc stock (NYSE: GSK) trades at $38 per share, about 20% below its peak level of over $47 seen in April 2022. In contrast, its peer Bristol Myers Squibb stock (NYSE: BMY) saw a 48% decline ...

GSK (GSK) closed the most recent trading day at $37.48, moving +0.35% from the previous trading session. This change outpaced the S&P 500's 0.22% loss on the day. Elsewhere, the Dow lost 0.31% ...

London-listed pharma giant GSK has raised its guidance after a strong second quarter beat market expectations, boosted by its ...

2024 Healthcare & Pharmaceuticalscategory EU regulator backs use of GSK's RSV shot in adults aged 50 to 59 July 26, 2024 U.S. oil and gas producer Occidental Petroleum said on Monday it would sell ...

Nearly 20% of US patients with chronic obstructive pulmonary disease skip or delay doses due to high monthly out-of-pocket ...

In early UK corporate news, GSK said its RSV drug received a positive assessment in Europe, while Pearson reported a half-year earnings fall but increased its dividend. Entain said its US BetMGM ...

Dengue Fever Treatment Market to a staggering USD 5435.25 million by 2033. This impressive growth, driven by a CAGR of 20%.